The SphenoCath device has shown significant potential as an advanced delivery method for biologics, peptides, and other regenerative therapies targeting the brain and central nervous system. While nebulized delivery methods can be effective in certain applications, the SphenoCath offers a more direct and potentially more efficient route of administration, which may improve absorption and overall therapeutic impact for select patients. 

 In addition to biologics and peptides, the device has also been utilized for products such as lidocaine in migraine related treatments, further demonstrating its versatility in neurological and regenerative applications. By providing targeted delivery closer to the intended treatment area, the SphenoCath may help enhance patient outcomes while supporting more precise therapeutic protocols.